Search

everythinglearnresearchcommunity

for

Search:↓

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Ethanol boosts brain steroid production by activating NMDA receptors, affecting memory formation.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Certain drugs that block specific enzymes can help treat prostate diseases.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Muscles can make their own androgens, which may help muscle growth.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

A natural steroid in the body may protect against eye damage in glaucoma.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride can cause serious side effects in some men, needing more research for treatment.